Celecoxib does not affect osteointegration of cementless total hip stems

Journal of Arthroplasty

Volumn 20, Issue SUPPL. 3, 2005, Pages 115-122

  Lionberger, David R ^a,b   Noble, Philip C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Orthopaedic Group   (United States)

Author keywords

Bone mineral density; Celecoxib; N telopeptide

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CELECOXIB;

ADULT; AGED; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ANALYSIS; FEMALE; FRACTURE HEALING; HUMAN; MALE; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE DENSITY; DOUBLE-BLIND METHOD; FEMALE; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSSEOINTEGRATION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PYRAZOLES; SULFONAMIDES;

EID: 26444586658     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2005.05.016     Document Type: Conference Paper

References (41)

1. T.A. Einhorn The role of cyclozygenase in bone repair Arthritis Res Ther 5 2002 5
2. T.A. Einhorn Do inhibitors of cyclooxygenase-2 impair bone healing? J Bone Miner Res 17 2002 977
3. M. Hukkanen Aseptic loosening of total hip replacement: macrophage expression of inducible nitric oxide synthase and cyclo-oxygenase-2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure J Bone Joint Surg 79-B 1997 467
4. O. Reikeraas Effects of ketorolac tromethamine and indomethacin on primary and secondary bone healing. An experimental study in rats Arch Orthop Trauma Surg 118 1998 50
5. J. Ro Effect of indomethacin on collagen metabolism on rat fracture in vitro Acta Orthop Scand 49 1978 323
6. J.C. Keller Effects of indomethacin on bone ingrowth J Orthop Res 7 1989 28
7. A.M. Simon, M.B. Manigrasso, and J.P. O'Connor Cyclo-oxygenase 2 function is essential for bone fracture healing J Bone Miner Res 17 2002 963
8. J. Ro Effect of indomethacin on fracture healing in rats Acta Orthop Scand 47 1976 588
9. D.J. Simmons Fracture healing perspectives Clin Orthop 1985 100
10. E. Sudamann Indomethacin-induced delayed fracture healing Arch Orthop 85 1976 155
11. R. Tozun Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97
12. D.E. Griswold, and J.L. Adams Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date Med Res Rev 16 1996 181
13. P.E. Lipsky The clinical potential of cyclooxygenase-2-specific inhibitors Am J Med 106 1999 51S
14. S.B. Trippel The unmet anti-inflammatory needs in orthopedics Am J Orthop 28 1999 3
15. W.G. Bensen Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized control trial Mayo Clin Proc 74 1999 1095
16. L.S. Simon Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial JAMA 282 1999 1921
17. J. Fort Celecoxib, a COX-2-specific inhibitor: the clinical data Am J Orthop 28 3 Suppl 1999 13
18. C.J. Smith Pharmacological analysis of cyclooxygenase-1 in inflammation Proc Natl Acad Sci U S A 95 1998 13313
19. R. Sinatra Role of cox-2 inhibitors in the evolution of acute pain management J Pain Symptom Manage 24 1 Suppl 2002 S18
20. T.D. Warner Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proc Natl Acad Sci U S A 96 1999 7563
21. A. Buanandran Effects of perioperative administration of cycloxgenase inhibition of pain management and recovery of function after total knee replacement JAMA 290 2003 2411
22. W.B. White Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal anti-inflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis Am J Ther 11 2004 244
23. W.B. White Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib Am J Cardiol 92 2003 411
24. M. Mamdani Cyclo-oxygenase-2 inhibitors versus non-selective versus non-selective non steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study Lancet 363 2004 1751
25. F. Camu The role of Cox-2 inhibitors in pain modulation Drugs 1 63 Suppl 2003 1
26. T.P. Malan Jr The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery Anesth Analg 100 2005 454
27. R. Reynolds The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty J Pain Symptom Manage 25 2003 133
28. L.C. Gerstenfeld Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs J Orthop Res 21 2003 670
29. Bainbridge PR, et al. Osteoporosis treatment monitoring: utility of bone turnover markers. Northern General Hospital, Sheffield, United June 15, 2000 ORS mtg; 2000
30. J.B. Kiratili Determination of bone mineral density by dual x-ray absorptiometry in patients with uncemented total hip arthroplasty J Orthop Res 10 1992 836
31. D.F. Scott, and W.L. Jaffe Host-bone response to porous-coated cobalt-chrome and hydroxyapatite-coated titanium femoral components in hip arthroplasty: dual-energy x-ray absorptiometry analysis of paired bilateral cases at 5 to 7 years J Arthroplasty 11 1996 429
32. T. Okano Measurement of periprosthetic bone mineral density by dual-energy x-ray absorptiometry is useful for estimating fixation between the bone and the prosthesis in an early stage J Arthroplasty 17 2002 49
33. H. Kroger Evaluation of periprosthetic bone using dual-energy x-ray absorptiometry: precision of the method and effect of operation on bone mineral density J Bone Miner Res 11 1996 1526
34. W.N. Capello Quantification of periprosthetic bone mineral density changes using dual-energy x-ray absorptiometry: a prospective multicenter trial Paper was in progress and presented at annual AAOS mtg. In New Orleans on March 18-23 1998
35. C. Wurnig Six year results of a cementless stem with prophylaxis against heterotopic bone Clin Orthop 1999 150
36. L. Zhang Evidence for direct role of cox-2 in implant wear debris-induced osteolysis J Bone Miner Res 16 2001 660
37. S.B. Goodman Cyclooxygenase-2 (COX-2) selective nonsteroidal anti-inflammatory drugs (NSAIDS) decrease bone ingrowth in vivo AAOS, New Orleans 2003 annual mtg., paper no. 44, p. 16 2003
38. S.D. Boden Biologic factors affecting spinal fusion and bone regeneration Spine 24S 1995 102S
39. A.S. Virdi Bone regeneration and implant fixation strength are not adversely influenced by Cox 2 inhibition 50th Annual Meeting of the Orthopedic Research Society. Poster no. 0455 2004
40. C. Elder A cyclooxygenase-2 inhibitor impairs ligament healing in the rat Am Orthop Soc Sports Med 29 2001 801
41. S.S. Reuben The effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion Reg Anesth Pain Med 26 2001 590